Stock Movers: Kohl's CEO Fired, Eli Lilly Drug Dropped by CVS, Microsoft Surges on Cloud Growth

Kohl's Leadership Shakeup

• 🎯 Kohl's CEO Ashley Buchanan was removed from his position after the board discovered he directed the company to engage in a multi-million dollar consulting agreement with an individual he had a personal relationship with, without proper disclosure.
• 📈 Despite the internal turmoil, Kohl's shares rose approximately 7%, suggesting Wall Street's approval of the situation being addressed.
• ⚠️ The company has appointed an interim CEO from its board and is initiating a search for a permanent replacement.
• 📉 This comes after a challenging year for Kohl's, with shares down about 49% year-to-date.

Eli Lilly Faces Setback with Weight-Loss Drug

• 🏥 CVS Health announced it will stop stocking Eli Lilly's weight-loss drug Zepbound, opting instead for Novo Nordisk's Wegovy.
• 📉 This decision led to Eli Lilly shares dropping around 8%, impacting investor sentiment.
• 📊 Eli Lilly also cut its full-year earnings outlook, citing increased research and development costs.
• 📈 In contrast, Novo Nordisk shares saw a slight increase of about half a percent on the news.

Microsoft's Cloud Business Drives Stock Surge

• 🚀 Microsoft shares surged, contributing to the strong performance of the information technology sector.
• ☁️ The company's cloud business, Azure, was a significant highlight, with projected growth of up to 35%.
• 💡 This growth is attributed to sustained customer demand for cloud services and the company's AI services.
• ✅ Microsoft's third-quarter results beat expectations, demonstrating resilience amidst economic turbulence and tariffs.